Approvals/TGA/ENABLEX darifenacin 7.5mg (as hydrobromide) modified release tablet blister pack

Approved

STANDARD

ENABLEX darifenacin 7.5mg (as hydrobromide) modified release tablet blister pack

Aspen Pharmacare Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 22309d420595639c
Product Name: ENABLEX darifenacin 7.5mg (as hydrobromide) modified release tablet blister pack
Artg Id: 99418
Artg Name: ENABLEX darifenacin 7.5mg (as hydrobromide) modified release tablet blister pack
Sponsor: Aspen Pharmacare Australia Pty Ltd
Company Detail Path: /organization/aspen-pharmacare-australia-pty-ltd
Artg Date: 2005-03-16
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2013-CMI-01704-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2013-PI-01703-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

22309d420595639c

Type

Standard